Julia Jara
Nurse Practitioner · Wesley Chapel, FLNPI 1811246135
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 166 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,480 and has fallen 71.5% since, to $423 in 2025. Among nurse practitioner clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 166 payments — averaging $26.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$964
- GSK$435
- Bayer$376
- Novo Nordisk$361
- Johnson & Johnson$356
- AbbVie$342
- plus $1K from 17 others
What the payments were for
- Food & beverage$4,324100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 36 | $964 |
| GSK | 18 | $435 |
| Bayer | 8 | $376 |
| Novo Nordisk | 20 | $361 |
| Johnson & Johnson | 3 | $356 |
| AbbVie | 14 | $342 |
| Boehringer Ingelheim | 11 | $275 |
| Pfizer | 11 | $223 |
| Boston Scientific | 3 | $199 |
| Lucid Diagnostics Inc. | 8 | $128 |
| Shield Therapeutics Inc | 5 | $89 |
| Lilly USA, LLC | 5 | $87 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $78 |
| Nevro Corp. | 4 | $77 |
| Currax Pharmaceuticals LLC | 5 | $73 |
| Myriad Women's Health, Inc. | 1 | $67 |
| Amgen | 3 | $56 |
| Dexcom, Inc. | 1 | $32 |
| Gilead | 2 | $30 |
| Upsher-smith Laboratories LLC | 1 | $21 |
| Phadia US Inc. | 1 | $20 |
| Stryker | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$356
- ACCOLADE SR$152
- FARXIGA$126
- JARDIANCE$121
- Enhertu$121
- Kerendia$121
- QULIPTA$119
- UBRELVY$119
- TRELEGY ELLIPTA$103
How this compares
$4,324 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 13 | $22,424 |
| EliquisApixaban | 15 | $17,674 |
| FarxigaDapagliflozin Propanediol | 13 | $17,595 |
| XareltoRivaroxaban | 16 | $14,150 |
| Glipizide ErGlipizide | 56 | $1,028 |
| Celecoxib | 19 | $751 |
| Losartan Potassium | 108 | $611 |
| Nifedipine ErNifedipine | 23 | $505 |
| Rosuvastatin Calcium | 45 | $467 |
| Levothyroxine Sodium | 60 | $446 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 18 | $440 |
| Atorvastatin Calcium | 87 | $421 |
| Pantoprazole Sodium | 54 | $415 |
| Montelukast Sodium | 52 | $410 |
| Duloxetine Hcl | 27 | $409 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $361 | $22,42413 claims |
| PfizerEliquis | $223 | $17,67415 claims |
| AstraZenecaFarxiga | $964 | $17,59513 claims |
| Johnson & JohnsonXarelto | $356 | $14,15016 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Wesley Chapel
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.